Added to YB: 2026-02-02
Pitch date: 2026-01-29
LONN.SW [bullish]
Lonza Group AG
+1.55%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
Market Cap
CHF 38.4B
Pitch Price
CHF 530.00
Price Target
N/A
Dividend
0.91%
EV/EBITDA
20.64
P/E
42.25
EV/Sales
6.42
Sector
Life Sciences Tools and Services
Category
growth
Lonza (LONN Switzerland): advanced synthesis steps into the spotlight as margins reset higher
LONN.SW (update): 2025 inflection in profitability with core EBITDA well above guidance/consensus. Advanced Synthesis transforming into core earnings driver w/ accelerating sales growth & expanding margins. Double-digit 2026 growth guided + further margin expansion despite FX headwinds & C&G weakness. Operational leverage finally asserting itself after years of heavy investment.
Read full article (2 min)